✦ LIBER ✦

Stability of the activated partial thromboplastin time used to monitor unfractionated heparin

✍ Scribed by M. RAY

Book ID: 109152660
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 135 KB
Volume: 6
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2008.03101.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interlaboratory agreement in the monitor

Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time

✍ A. CUKER; B. PTASHKIN; B. A. KONKLE; S. W. PIPE; H. C. WHINNA; X. L. ZHENG; D. B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

Interlaboratory agreement in the monitor

Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time: a rebuttal

✍ S. KITCHEN; F. E. PRESTON; I. JENNINGS; D.P. KITCHEN; T.A.L. WOODS; I. WALKER 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Interlaboratory agreement in the monitor

Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time: reply to a rebuttal

✍ A. CUKER; D. B. CINES; E. S. POLLAK 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Bedside monitoring of heparin therapy: c

Bedside monitoring of heparin therapy: comparison of activated clotting time to activated partial thromboplastin time

✍ Reiner, Jonathan S. ;Coyne, Karin S. ;Lundergan, Conor F. ;Ross, Allan M. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB

Heparin anticoagulation is utilized during and after interventionai cardiac catheterization procedures to reduce the risk of acute thrombotic coronary artery occlusion. The short half-life of heparin, the importance of maintaining therapeutic anticoaguiation, and the time delay inherent in the proce

Use of the activated partial thromboplas

Use of the activated partial thromboplastin time for monitoring heparin therapy: Problems and possible solutions

✍ Leon Poller; Jean M. Thomson; David A. Taberner 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 436 KB

Standardization of the activated partial

Standardization of the activated partial thromboplastin time for monitoring of heparin therapy: Where should we go?

✍ Antonius M. H. P. van den Besselaar 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 381 KB